Skip to main content
Elsevier
View Cart

Peptide and Peptidomimetic Therapeutics

From Bench to Bedside

  • 1st Edition - September 22, 2022
  • Latest edition
  • Editors: Nir Qvit, Samuel J.S. Rubin
  • Language: English

Peptide and Peptidomimetic Therapeutics: From Bench to Beside offers applied, evidence-based instruction on developing and applying peptide therapeutics in disease treatment… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Peptide and Peptidomimetic Therapeutics: From Bench to Beside offers applied, evidence-based instruction on developing and applying peptide therapeutics in disease treatment, driving drug discovery, and improving patient care. Here, researchers, clinicians and students will find tools to harness the full power of peptides and peptidomimetics and improve bioavailability, stability, efficiency and selectivity of new therapeutics and their application in treatment plans. More than 20 leaders in the field share their approaches for identifying and advancing peptide and peptidomimetic therapeutics. Topics examined run from "bench to bedside," beginning with fundamental peptide science, protein-protein interactions and peptide synthesis.

Later chapters examine modes for peptide drug delivery, including cell penetration peptide and peptidomimetic delivery, as well as the targeting of specific disease types, peptide therapeutics as applied to infectious disease, cancer, metabolic disorders, neurodegenerative disorders, and skin disorders, and antiparasitic and immunosuppressive peptidomimetics.

Key features

  • Helps researchers and clinicians harness the full of power of peptides and peptidomimetics in their daily work and drug discovery
  • Features chapters running from “bench to bedside”, providing a thorough grounding in fundamental peptide science, drug delivery methods, and targeting of specific disease types
  • Features chapter contributions from international leaders in peptide science and drug development

Readership

Active researchers in biochemistry, medical chemistry, molecular biology, cell biology, pharmacology; clinician scientists

Table of contents

History

1. Therapeutic peptides: historical perspectives and current development trends

Basic science

2. Therapeutic peptidomimetics: targeting the undruggable space

3. Tailoring peptides and peptidomimetics for targeting protein-protein interactions

4. Advances in peptide synthesis

5. Stapled peptidomimetic therapeutics

6. Ring closing metathesis

Drug discovery

7. The current state of backbone cyclic peptidomimetics and their application to drug discovery

8. Pharmacokinetics and pharmacodynamics of peptidomimetics

9. Formulations of peptides and peptidomimetics

10. Cell-penetrating peptides

11. Intracellular peptides as drug prototypes

12. Applications of computational three-dimensional structure prediction for antimicrobial peptides

Therapeutic applications

13. Knottin peptidomimetics as therapeutics

14. Venom peptidomimetics as therapeutics

15. Therapeutic peptides targeting protein kinase: progress, challenges and future directions, featuring cancer and cardiovascular disease

16. Therapeutic peptidomimetics for infectious diseases

17. Antiparasitic therapeutic peptidomimetics

18. Peptides and antibiotic resistance

19. Antimicrobial peptides and the skin and gut microbiomes

20. Peptide and peptidomimetic based vaccines

21. Therapeutic peptidomimetics for cancer treatment

22. Immunomodulatory peptidomimetics for multiple sclerosis therapy – the story of glatiramer acetate (Copaxone)

23. Therapeutic peptidomimetics in metabolic diseases

24. Therapeutic peptidomimetics in anesthesiology

25. Cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease

26. Non-cardiovascular-derived therapeutic peptidomimetics in cardiovascular disease

Drug development

27. Clinical and preclinical data on therapeutic peptides

28. Therapeutic peptides: manufacturing and market

29. Future perspectives on peptide therapeutics

Product details

  • Edition: 1
  • Latest edition
  • Published: September 22, 2022
  • Language: English

About the editors

NQ

Nir Qvit

Dr. Nir Qvit completed his doctorate in organic chemistry, at the Hebrew University in 2008. His doctorate work focused on developing different strategies for synthesis of small molecules, peptides and peptidomimetics (modified peptides) for various therapeutic applications. Dr. Qvit joined Bar-Ilan University’s team of researchers in the Galilee in October 2017, and is currently the Principle Investigator of the Laboratory for Chemical Biology of Protein-Protein Interactions in the Faculty of Medicine. Dr. Qvit’s current research focuses on development of novel tools to regulate protein-protein interactions. He uses a rational approach to design and develop short peptides and peptidomimetics derived from protein regulatory domains to modulate their function in a selective manner. Dr. Qvit is a reviewer for many scientific journals, including the Journal of Medicinal Chemistry and Journal of Peptide Science; and he was a guest editor of a special issue of Current Topics in Medicinal Chemistry.
Affiliations and expertise
Principle Investigator, Laboratory for Chemical Biology of Protein-Protein Interactions, Faculty of Medicine

SR

Samuel J.S. Rubin

Dr. “Yoni” Samuel J. S. Rubin completed his PhD in immunology at Stanford University School of Medicine in 2019, followed by postdoctoral training and MD at the same institution. His research focuses on better understanding the molecular and cellular mechanisms underlying chronic immune-mediated diseases and using this knowledge to develop safer, cheaper, and more effective tools for detecting and treating illness worldwide. In the field of mucosal immunology and immune cell trafficking, Dr. Rubin’s findings have inspired the development of novel blood-based methods for detection of gastroenterological conditions. His work has also led to the development of precision medicine therapeutics for the treatment of chronic auto-inflammatory conditions. Dr. Rubin is especially appreciative for the circuitous and often unexpected path that continues to characterize his career. Especially influential were the many instructors and mentors that inspired his dedication to teaching the student and shaped his past and ongoing endeavors. He has served as a guest editor for Current Topics in Medicinal Chemistry and continues to serve as a reviewer for numerous scientific journals. Amongst other awards and recognitions, Dr. Rubin has received the United States National Science Foundation Graduate Research Fellowship and the Hugh McDevitt Prize in Immunology.
Affiliations and expertise
Department of Medicine, Stanford University School of Medicine, Stanford, California, USA

View book on ScienceDirect

Read Peptide and Peptidomimetic Therapeutics on ScienceDirect